We have located links that may give you full text access.
Efficacy of dexamethasone, salbutamol, and reduced respirable particulate concentration on aerobic capacity in horses with smoke-induced mild asthma.
Journal of Veterinary Internal Medicine 2020 January 19
BACKGROUND: Mild asthma in horses decreases racing performance and impairs gas exchange. The efficacy of treatment on performance is unknown.
HYPOTHESIS: Treatment targeting lung inflammation improves V ˙ O2 peak in horses with mild asthma.
ANIMALS: Thoroughbred polo horses (n = 12) with smoke-induced mild asthma. Horses were exposed to increased ambient particulate matter (35.51 μg/m3 [PM2.5 ]; day mean, centrally measured) from day -33 to 0, from bushfire smoke (natural model).
METHODS: Prospective, randomized, placebo-controlled, double-blinded clinical trial. All horses completed 3 V ˙ O2 peak tests, measuring aerobic and anaerobic variables: day 0 -baseline; day 16 -after dexamethasone (20 mg IM q24h; DEX, n = 6) or saline treatment (SALINE, n = 6), under improved ambient PM2.5 concentrations (7.04 μg/m3 ); day 17-15-30mins after inhaled salbutamol (1500 μg). Bronchoalveolar lavage and mucus scoring were performed on day -8 and day 20. Linear mixed effects models were used to examine the effects of timepoint and treatment group on BAL differential cell counts, mucus scores, aerobic and anaerobic variables.
RESULTS: Horses' mucus scores improved significantly from day -8 to 20 by 1.27 ± .38 (P = .01). There was a significant increase in V ˙ O2 peak of 15.5 ± 4.0 mL(min.kg)-1 from day 0 to 17 (P = .002), representing an average (mean) increase in V ˙ O2 peak of 13.2%. There was no difference in V˙O2 peak between treatment groups (SALINE versus DEX) at any timepoint.
CONCLUSIONS AND CLINICAL IMPORTANCE: This study highlighted the key role of improved air quality on functionally important airway inflammation. Evidence provided is central to increasing owner compliance regarding improved air quality for the treatment and prevention of mild asthma.
HYPOTHESIS: Treatment targeting lung inflammation improves V ˙ O2 peak in horses with mild asthma.
ANIMALS: Thoroughbred polo horses (n = 12) with smoke-induced mild asthma. Horses were exposed to increased ambient particulate matter (35.51 μg/m3 [PM2.5 ]; day mean, centrally measured) from day -33 to 0, from bushfire smoke (natural model).
METHODS: Prospective, randomized, placebo-controlled, double-blinded clinical trial. All horses completed 3 V ˙ O2 peak tests, measuring aerobic and anaerobic variables: day 0 -baseline; day 16 -after dexamethasone (20 mg IM q24h; DEX, n = 6) or saline treatment (SALINE, n = 6), under improved ambient PM2.5 concentrations (7.04 μg/m3 ); day 17-15-30mins after inhaled salbutamol (1500 μg). Bronchoalveolar lavage and mucus scoring were performed on day -8 and day 20. Linear mixed effects models were used to examine the effects of timepoint and treatment group on BAL differential cell counts, mucus scores, aerobic and anaerobic variables.
RESULTS: Horses' mucus scores improved significantly from day -8 to 20 by 1.27 ± .38 (P = .01). There was a significant increase in V ˙ O2 peak of 15.5 ± 4.0 mL(min.kg)-1 from day 0 to 17 (P = .002), representing an average (mean) increase in V ˙ O2 peak of 13.2%. There was no difference in V˙O2 peak between treatment groups (SALINE versus DEX) at any timepoint.
CONCLUSIONS AND CLINICAL IMPORTANCE: This study highlighted the key role of improved air quality on functionally important airway inflammation. Evidence provided is central to increasing owner compliance regarding improved air quality for the treatment and prevention of mild asthma.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app